Business Description
![Adverum Biotechnologies Inc Adverum Biotechnologies Inc logo](https://static.gurufocus.com/logos/0C0000AOW4.png?14)
Adverum Biotechnologies Inc
NAICS : 325412
SIC : 2834
ISIN : US00773U1088
Description
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.6 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.41 | |||||
Debt-to-EBITDA | -0.65 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 4.2 | |||||
3-Year EPS without NRI Growth Rate | 5.6 | |||||
3-Year FCF Growth Rate | 5.3 | |||||
3-Year Book Growth Rate | -43 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 41.26 | |||||
9-Day RSI | 41.13 | |||||
14-Day RSI | 39.53 | |||||
6-1 Month Momentum % | 10.56 | |||||
12-1 Month Momentum % | -47.04 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.24 | |||||
Quick Ratio | 9.24 | |||||
Cash Ratio | 8.97 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.3 | |||||
Shareholder Yield % | -65.59 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -2570.78 | |||||
ROE % | -85.87 | |||||
ROA % | -48.89 | |||||
ROIC % | -111.74 | |||||
ROC (Joel Greenblatt) % | -153.04 | |||||
ROCE % | -61.01 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 19.52 | |||||
PB Ratio | 0.79 | |||||
Price-to-Tangible-Book | 0.79 | |||||
EV-to-EBIT | -0.21 | |||||
EV-to-Forward-EBIT | -0.24 | |||||
EV-to-EBITDA | -0.22 | |||||
EV-to-Forward-EBITDA | -0.23 | |||||
EV-to-Revenue | 7.18 | |||||
EV-to-Forward-Revenue | 29.43 | |||||
EV-to-FCF | -0.28 | |||||
Price-to-Net-Current-Asset-Value | 1.27 | |||||
Price-to-Net-Cash | 1.34 | |||||
Earnings Yield (Greenblatt) % | -476.19 | |||||
FCF Yield % | -63.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Adverum Biotechnologies Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 3.6 | ||
EPS (TTM) ($) | -10.2 | ||
Beta | -0.96 | ||
Volatility % | 129.69 | ||
14-Day RSI | 39.53 | ||
14-Day ATR ($) | 0.426463 | ||
20-Day SMA ($) | 7.21951 | ||
12-1 Month Momentum % | -47.04 | ||
52-Week Range ($) | 6.49 - 29.5 | ||
Shares Outstanding (Mil) | 20.76 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Adverum Biotechnologies Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Adverum Biotechnologies Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Adverum Biotechnologies Inc Frequently Asked Questions
What is Adverum Biotechnologies Inc(LTS:0HA3)'s stock price today?
The current price of LTS:0HA3 is $6.79. The 52 week high of LTS:0HA3 is $29.50 and 52 week low is $6.49.
When is next earnings date of Adverum Biotechnologies Inc(LTS:0HA3)?
The next earnings date of Adverum Biotechnologies Inc(LTS:0HA3) is 2024-08-09 Est..
Does Adverum Biotechnologies Inc(LTS:0HA3) pay dividends? If so, how much?
Adverum Biotechnologies Inc(LTS:0HA3) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |